BRANDY LAURENZI: Open Payments
NPI 1609178714 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,962 in 155 payments from 25 companies in 2025. Trend: 2023 $2,392 · 2024 $2,947 · 2025 $2,962
Food & beverage: $2,962
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $378 |
| Neurocrine BioSciences, Inc. | 17 | $344 |
| Novo Nordisk Inc | 18 | $336 |
| PFIZER INC. | 12 | $238 |
| Lilly USA, LLC | 9 | $200 |
| Amgen Inc. | 13 | $199 |
| GlaxoSmithKline, LLC. | 11 | $194 |
| Otsuka America Pharmaceutical, Inc. | 10 | $179 |
| ABBVIE INC. | 13 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $169 |
Products named: INGREZZA, REXULTI, AIRSUPRA, TRELEGY ELLIPTA, Rybelsus, EVENITY, NURTEC ODT, LOKELMA.
Industry payments across AL — which companies pay providers there.
